These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 32748749)

  • 1. Pentamethylquercetin Inhibits Hepatocellular Carcinoma Progression and Adipocytes-induced PD-L1 Expression via IFN-γ Signaling.
    Li Z; Gao WQ; Wang P; Wang TQ; Xu WC; Zhu XY; Liu H
    Curr Cancer Drug Targets; 2020; 20(11):868-874. PubMed ID: 32748749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipocytes promote tumor progression and induce PD-L1 expression via TNF-α/IL-6 signaling.
    Li Z; Zhang C; Du JX; Zhao J; Shi MT; Jin MW; Liu H
    Cancer Cell Int; 2020; 20():179. PubMed ID: 32477009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentamethylquercetin induces adipose browning and exerts beneficial effects in 3T3-L1 adipocytes and high-fat diet-fed mice.
    Han Y; Wu JZ; Shen JZ; Chen L; He T; Jin MW; Liu H
    Sci Rep; 2017 Apr; 7(1):1123. PubMed ID: 28442748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chrysin inhibits hepatocellular carcinoma progression through suppressing programmed death ligand 1 expression.
    Rong W; Wan N; Zheng X; Shi G; Jiang C; Pan K; Gao M; Yin Z; Gao ZJ; Zhang J
    Phytomedicine; 2022 Jan; 95():153867. PubMed ID: 34923234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon regulatory factor 1 (IRF-1) and IRF-2 regulate PD-L1 expression in hepatocellular carcinoma (HCC) cells.
    Yan Y; Zheng L; Du Q; Yan B; Geller DA
    Cancer Immunol Immunother; 2020 Sep; 69(9):1891-1903. PubMed ID: 32377817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventing mitochondrial PD-L1 suppressed IFN-γ-induced cancer stemness in hepatocellular carcinoma by sensitizing sorafenib-induced ferroptosis.
    Li T; Huang HY; Qian B; Wang WH; Yuan Q; Zhang HY; He J; Ni KJ; Wang P; Zhao ZY; He JL; Fu SW; Xu L; Lin YC; Lin ZN
    Free Radic Biol Med; 2024 Feb; 212():360-374. PubMed ID: 38171407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mulberry leaf extract inhibit hepatocellular carcinoma cell proliferation via depressing IL-6 and TNF-α derived from adipocyte.
    Chang CH; Chang YT; Tseng TH; Wang CJ
    J Food Drug Anal; 2018 Jul; 26(3):1024-1032. PubMed ID: 29976395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paeoniflorin inhibits hepatocellular carcinoma growth by reducing PD-L1 expression.
    Gao M; Zhang D; Jiang C; Jin Q; Zhang J
    Biomed Pharmacother; 2023 Oct; 166():115317. PubMed ID: 37597322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lenvatinib Targets FGF Receptor 4 to Enhance Antitumor Immune Response of Anti-Programmed Cell Death-1 in HCC.
    Yi C; Chen L; Lin Z; Liu L; Shao W; Zhang R; Lin J; Zhang J; Zhu W; Jia H; Qin L; Lu L; Chen J
    Hepatology; 2021 Nov; 74(5):2544-2560. PubMed ID: 34036623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obovatol inhibits proliferation, invasion and immune escape of hepatocellular carcinoma cells through modulating the JAK/STST3/PD-L1 pathway.
    Liao C; Zhao M; Jiang X; Sun W; Zeng Q; Cai C; Yin X
    Int Immunopharmacol; 2024 Nov; 141():112775. PubMed ID: 39146776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYC inhibition increases PD-L1 expression induced by IFN-γ in hepatocellular carcinoma cells.
    Zou J; Zhuang M; Yu X; Li N; Mao R; Wang Z; Wang J; Wang X; Zhou H; Zhang L; Shi Y
    Mol Immunol; 2018 Sep; 101():203-209. PubMed ID: 30007230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentamethylquercetin improves adiponectin expression in differentiated 3T3-L1 cells via a mechanism that implicates PPARγ together with TNF-α and IL-6.
    Chen L; He T; Han Y; Sheng JZ; Jin S; Jin MW
    Molecules; 2011 Jul; 16(7):5754-68. PubMed ID: 21734632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells.
    Yuan LW; Jiang XM; Xu YL; Huang MY; Chen YC; Yu WB; Su MX; Ye ZH; Chen X; Wang Y; Lu JJ
    Phytomedicine; 2021 Jan; 80():153394. PubMed ID: 33130472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FAT10 induces immune suppression by upregulating PD-L1 expression in hepatocellular carcinoma.
    Wang Q; Tan W; Zhang Z; Chen Q; Xie Z; Yang L; Tang C; Zhuang H; Wang B; Jiang J; Ma X; Wang W; Hua Y; Shang C; Chen Y
    Apoptosis; 2024 Oct; 29(9-10):1529-1545. PubMed ID: 38824477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-talk between TNF-α and IFN-γ signaling in induction of B7-H1 expression in hepatocellular carcinoma cells.
    Li N; Wang J; Zhang N; Zhuang M; Zong Z; Zou J; Li G; Wang X; Zhou H; Zhang L; Shi Y
    Cancer Immunol Immunother; 2018 Feb; 67(2):271-283. PubMed ID: 29090321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed Death Ligand-1 (PD-L1) Regulated by NRF-2/MicroRNA-1 Regulatory Axis Enhances Drug Resistance and Promotes Tumorigenic Properties in Sorafenib-Resistant Hepatoma Cells.
    Li D; Sun FF; Wang D; Wang T; Peng JJ; Feng JQ; Li H; Wang C; Zhou DJ; Luo H; Fu ZQ; Zhang T
    Oncol Res; 2020 Dec; 28(5):467-481. PubMed ID: 32560747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abrine, an IDO1 inhibitor, suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibody in hepatocellular carcinoma.
    Liang X; Gao H; Xiao J; Han S; He J; Yuan R; Yang S; Yao C
    Front Immunol; 2023; 14():1185985. PubMed ID: 37334368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemcitabine-facilitated modulation of the tumor microenvironment and PD-1/PD-L1 blockade generate a synergistic antitumor effect in a murine hepatocellular carcinoma model.
    Wang H; He X; Fang D; Wang X; Guan J; Shi ZW; Chen X
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101853. PubMed ID: 34923183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pomegranate flower extract bidirectionally regulates the proliferation, differentiation and apoptosis of 3T3-L1 cells through regulation of PPARγ expression mediated by PI3K-AKT signaling pathway.
    Li T; Zhang L; Jin C; Xiong Y; Cheng YY; Chen K
    Biomed Pharmacother; 2020 Nov; 131():110769. PubMed ID: 33152931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.